Description
Deboc-cabazitaxel or De-boc-cabazitaxel is an impurity in the synthesis of cabazitaxel. The latter is an anti-cancer agent derived from taxol. Cabazitaxel is used in the treatment of castration-resistant prostate cancer.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Deboc-cabazitaxel or De-boc-cabazitaxel is an impurity in the synthesis of cabazitaxel. The latter is an anti-cancer agent derived from taxol. Cabazitaxel is used in the treatment of castration-resistant prostate cancer.
| Cas No. | 1638286-64-2 |
|---|---|
| Purity | ≥95% |
| Formula | C40H49NO12 |
| Formula Wt. | 735.83 |
| Synonym | De-boc-Cabazitaxel |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
ATR inhibitor.
Mixture of pyrantel, a thiophene, and pamoic ac...
VEGFR inhibitor.
Found in parsley.
Polyanionic sulfated glycosaminoglycan, endogen...
Sesquiterpene alcohol found in various essentia...
Endogenous peptide fragment, involved in vasoco...
MurA and isopentenyl mevalonate kinase inhibito...
Aromatase inhibitor.
β2-adrenergic agonist.
Hexokinase inhibitor, aerobic glycolysis inhibi...
Peptide, involved in paracrine and autocrine ce...
Prodrug
PKC activator, carcinogen.
Mycotoxin; F1F0 ATP synthase inhibitor.
Piperazine; FIASMA, D2 antagonist, hERG K+ chan...
NSAID; COX-1/2 inhibitor.
Dibenzofuran produced by lichens.
Isoleucyl-tRNA synthase inhibitor, osteoclast p...
PDEδ inhibitor.